Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Merck
Deloitte
Cipla
Fuji
US Army
Accenture
Boehringer Ingelheim
Cerilliant

Generated: January 18, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN STEARATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for erythromycin stearate and what is the scope of erythromycin stearate patent protection?

Erythromycin stearate
is the generic ingredient in eight branded drugs marketed by Bristol, Parke Davis, Warner Chilcott, Arbor Pharms Llc, Ani Pharms Inc, Lederle, Mylan, Purepac Pharm, Watson Labs, Bristol Myers Squibb, Pfizer, and Wyeth Ayerst, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and one drug master file entries for erythromycin stearate. Six suppliers are listed for this compound.
Pharmacology for ERYTHROMYCIN STEARATE

US Patents and Regulatory Information for ERYTHROMYCIN STEARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst WYAMYCIN S erythromycin stearate TABLET;ORAL 061675-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst WYAMYCIN S erythromycin stearate TABLET;ORAL 061675-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062089-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062121-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062089-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis ERYPAR erythromycin stearate TABLET;ORAL 062032-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062121-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ETHRIL 250 erythromycin stearate TABLET;ORAL 061605-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 061743-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis ERYPAR erythromycin stearate TABLET;ORAL 062032-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Accenture
Johnson and Johnson
Moodys
Express Scripts
Cerilliant
Healthtrust
Mallinckrodt
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot